Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma

Published:2016-01-10 Issue:2 Volume:34 Page:e1-e5
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Cai Xuemei¹,Bhattacharyya Shamik¹,Plitt Anna²,Raibagkar Pooja¹,LaBuzetta Jamie N.¹,Schleicher Stephen M.³,Munshi Nikhil C.⁴,Klein Joshua P.³

Affiliation:

1. Brigham and Women's Hospital; Massachusetts General Hospital; and Harvard Medical School, Boston, MA

2. Harvard Medical School, Boston, MA

3. Brigham and Women's Hospital; and Harvard Medical School, Boston, MA

4. Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.49.6166

Reference17 articles.

2. Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

3. A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies

4. A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuro-ophthalmic complications of modern anti-cancer drugs;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-12

2. Posterior reversible encephalopathy syndrome (PRES) and myeloma;Leukemia Research Reports;2024

3. Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma;OncoTargets and Therapy;2022-09

4. A Case of COVID-19 Presenting with Posterior Reversible Encephalopathy Syndrome;Turkish Journal Of Neurology;2021-10-04

5. Central Nervous System;Oncologic Emergency Medicine;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3